prof. dr. M.J. (Maarten) Postma

Professor Global Health Economics UMCG & RUG

prof. dr. M.J. (Maarten) Postma


  1. 2016
  2. Dik, J-W., Lokate, M., Kirste, A., Hendrix, R., Lo-Ten-Foe, J. R., Postma, M., ... Friedrich, A. (2016). Assessing the impact of infection prevention – an incremental cost-benefit analysis. Poster session presented at 26th European Congress of Clinical Microbiology and Infectious Diseases, Amsterdam, Netherlands.
  3. Mafirakureva, N., Nyoni, H., Nkomo, S. Z., Jacob, J. S., Chikwereti, R., Musekiwa, Z., ... van Hulst, M. (2016). The costs of producing a unit of blood in Zimbabwe. Transfusion, 56(3), 628-636.
  4. Bindels, J., Ramaekers, B., Ramos, I. C., Mohseninejad, L., Knies, S., Grutters, J., ... Joore, M. (2016). Use of Value of Information in Healthcare Decision Making: Exploring Multiple Perspectives. Pharmacoeconomics, 34(3), 315-322.
  5. 2015
  6. Dik, J-W., Dinkelacker, A., Lo-Ten-Foe, J. R., Vemer, P., Postma, M., Sinha, B., & Friedrich, A. (2015). Cost analysis of nosocomial outbreaks in an academic hospital setting. Poster session presented at 55th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Diego, CA, United States.
  7. Pitman, J. P., Basavaraju, S. V., Shiraishi, R. W., Wilkinson, R., von Finckenstein, B., Lowrance, D. W., ... Smit Sibinga, C. T. (2015). Namibia's transition from whole blood-derived pooled platelets to single-donor apheresis platelet collections. Transfusion, 55(7), 1685-1692.
  8. Heeg, B. M., Liwing, J., Karstorp, S., Postma, M., Silvennoinen, R., Putkonen, M., ... Nahi, H. (2015). Can overall survival be improved in elderly multiple myeloma patients? Haematologica, 100, 517. [Abstract: E1289].
  9. Liwing, J., Heeg, B. M., Karstorp, S., Postma, M., Silvennoinen, R., Putkonen, M., ... Nahi, H. (2015). Is a deep response the key to successful treatment of multiple myeloma? Haematologica, 100, 92.
  10. Mihajlović, J., Bax, P., Van Breugel, E., Blommestein, H. M., Hoogendoorn, M., Hospes, W., & Postma, M. J. (2015). Micro-costing study of rituximab subcutaneous injection versus intravenous infusion in dutch setting. Haematologica, 100, 582.
  11. Liwing, J., Heeg, B. M., Karstorp, S., Postma, M., Silvennoinen, R., Putkonen, M., ... Nahi, H. (2015). Trial efficacy vs real world effectiveness in first line treatment of multiple myeloma. Haematologica, 100, 512-513. [E1277].
  12. Nyashadzaishe Mafirakureva, N., Mberi, Y. T., Khoza, S., Mvere, D. A., Emmanuel, J. C., Postma, M. J., & Van Hulst, M. (2015). Blood transfusion practices in obstetric care at a tertiary referral hospital in Zimbabwe. Vox Sanguinis, 109, 100.
  13. Mapako, T., Parirewa, J. J., Emmanuel, J. C., Mvere, D. A., Massundah, E., Mavunganidze, G., ... Van Hulst, M. (2015). Challenges of using HIV as a primary risk indicator: Need for integrated blood donor risk management model. Vox Sanguinis, 109, 45-46.
Previous 1 2 3 4 5 6 7 8 ...15 Next

ID: 193217